tbuckley/cabot-search huggingface dataset:
44164 Comparative Risk of Non-Melanoma Skin Cancer Associated with Prior Use of Ingenol Mebutate vs Imiquimod
Authors: Megha Patel, William Ting
Journal: Journal of the American Academy of Dermatology (2023)

Background: Actinic keratosis is a premalignant skin disease that can develop into non-melanoma skin cancers (NMSC)1. In 2020, ingenol mebutate was withdrawn from the U.S. market2 partly triggered by earlier European studies that concluded ingenol mebutate increases the risk of NMSC in treated areas compared to imiquimod3,4. In this retrospective cohort study, we re-examine the comparative risks of subsequent NMSC associated with prior application of both pharmacotherapeutic agents. In total, 1,133 patients were observed after being prescribed ingenol mebutate 0.015% gel, ingenol mebutate 0.05% gel, imiquimod 3.75% cream or imiquimod 5% cream from 2010 to 2020. The primary outcome studied was the proportion of patients who developed NMSC in the same anatomical region the medication was applied within 5 years of prescription date. The incidence rate of NMSC was lower in the ingenol mebutate 0.05% gel group (N=329, 8.5%) than the ingenol mebutate 0.015% gel (N=355, 14.9%) group (p=0.008, p<0.01); The imiquimod 3.75% cream group had a lower rate (N=417, 2.16%) than the 5% cream group (N=32, 3.13%) (p=0.59, p>0.01). The incidence rate was lower in the imiquimod group than the ingenol mebutate group (p=0.0001, p<0.01). This patient cohort may represent one of the largest in the U.S. to date comparing the risk in subsequent NMSC development arising from ingenol mebutate versus imiquimod application with findings confirming the earlier studies.
42639 Frontal fibrosing alopecia: Characterization of the histopathology in the interparietal region in daily clinical practice
Authors: Marta Gonzalez Canete, Ana Rodriguez-villa Lario, David Vega Diez, Elena Lucia Pinto Pulido, Elena Garcia Verdu, Maria Dolores Velez Velazquez, Susana Medina Montalvo, Isabel Polo Rodriguez, Lidia Trasobares Marugan, Alba Gomez Zubiaur
Journal: Journal of the American Academy of Dermatology (2023)
44031 The Reading man flap as an option for reconstruction in areas subject to flexo-extension movements
Authors: Ingrid Hiltun, Iñigo Martinez-de-Espronceda, Jorge Arostegui, Maialen Azona-Rodríguez, Jone Sarriugarte, Maria Eugenia Iglesias- Zamora
Journal: Journal of the American Academy of Dermatology (2023)
43515 Malignant syphilis: a case series
Authors: Sara Orozco - Jimenez, Pedro Juan Saldarriaga - Muñoz, Valeria Arciniegas - Grisales, Carolina Arango - Buitrago, Ana Maria Mejia - Giraldo, Susana Chiquito - Garcia, Angela María Londoño - García, Maria del Pilar Marquez - Moron
Journal: Journal of the American Academy of Dermatology (2023)
41956 Chronic spontaneous urticaria and hypertension, a glance from a dermatologic center
Authors: David Castillo-Molina, Jennipher Andrea Blanco-Gomez, Sofia Bernal-Alfonso, Jesus Daniel Fierro-Lozada, Natalia Muñoz-Angulo, Samanda J. Suarez-García, Daniela Gutierrez-Murcia, Penelope A. Hirt
Journal: Journal of the American Academy of Dermatology (2023)
43072 Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized Phase 3 clinical trials
Authors: Adelaide Hebert, Carsten Flohr, H. Chih-ho Hong, Alan Irvine, Evangeline Pierce, Hany Elmaraghy, Wen Xu, Sreekumar Pillai, Zach Dawson, Elaine Siegfried, Stephan Weidinger
Journal: Journal of the American Academy of Dermatology (2023)
43858 The 31-gene expression profile test for cutaneous melanoma identifies patients with stage IB- IIA disease who have recurrence risk similar to that of stage IIB-IIC disease
Authors: Abel Jarell, Abel Jarell, Sonia K. Morgan-Linnell, Brian Martin, Christine N. Bailey, Matthew S. Goldberg, Sarah J. Kurley, Ryan Weight
Journal: Journal of the American Academy of Dermatology (2023)
43150 Teledermatology evaluation as presurgical tool for Dermato-Oncology patients
Authors: Lidia Carbonero-Jiménez, Elvira Molina-Figuera, David Mateos-Moreno, Cristina Romera-de-Blas, María Cotarelo-Hernández, Natalia Aranda- Sánchez, M. Victoria Signes-Costa-Smith, M. José Carrera-Hernández, J. José Amoros-Oliva, Cristina Perez-Hortet
Journal: Journal of the American Academy of Dermatology (2023)
42910 Validation of the Sleep Numeric Rating Scale (Sleep-NRS) for measuring sleep quality in adults with Prurigo Nodularis (PN): Results from dupilumab clinical studies
Authors: Donia Bahloul, Ryan Thomas, Stephanie Rhoten, Cristina Ivanescu, Sonja Ständer, Brian Kim, John O’Malley, Ashish Bansal, Jerome Msihid, Ella Brookes
Journal: Journal of the American Academy of Dermatology (2023)
43923 UVB induced melanogenesis in re-innervated human skin is enhanced by a paracrine cross talk between melanocytes and nerve fibers involving semaphorine-4A
Authors: Onur Erigboz, Moe Tsutsumi, Ilaria Piccini, Kentaro Kajiya, Marta Bertolini
Journal: Journal of the American Academy of Dermatology (2023)
43110 Deucravacitinib, a Selective Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: PASI Body Region and Component Scores in a Phase 3 Trial
Authors: Yayoi Tada, Shinichi Imafuku, Yukari Okubo, Mamitaro Ohtsuki, Yanqiu Shao, Elizabeth Colston, Andrew Napoli, Lauren Hippeli, Subhashis Banerjee, Akimichi Morita
Journal: Journal of the American Academy of Dermatology (2023)
44145 Early Skin and Early Enthesitis Responses in Psoriatic Arthritis Patients Treated with Guselkumab Associate with Long-term Response: Pooled Post Hoc Analyses Through 1 Year of Two Phase 3 Studies
Authors: Laura C. Coates, Julio Ramírez, Dennis McGonagle, Sibel Aydin, Miriam Zimmermann, Francois Nantel, May Shawi, Emmanouil Rampakakis, Peter Nash, Philip Mease
Journal: Journal of the American Academy of Dermatology (2023)
42244 An in vitro study of nail perforation ability of Neoscytalidium dimidiatum: the postulate of onychomycosis caused by the non-dermatophyte
Authors: Pantaree Kobkurkul, Sumanas Bunyaratavej, Charussri Leeyaphan, Poramin Patthamalai, Kanyalak Munprom, Lalita Matthapan, Penvadee Pattanaprichakul
Journal: Journal of the American Academy of Dermatology (2023)
42640 Efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Final results from the Phase 3 SUNSHINE and SUNRISE trials
Authors: Alexa B. Kimball, Gregor B.E. Jemec, Afsaneh Alavi, Ziad Reguiai, Alice Gottlieb, Magdalena B. Wozniak, Lorenz Uhlmann, Angela Llobet Martinez, Claire Field, Shoba Ravichandran, Elisa Muscianisi
Journal: Journal of the American Academy of Dermatology (2023)
42601 Assessment of Bioequivalence Between Candidate Biosimilar AVT04 and Reference Ustekinumab
Authors: Fausto Berti, Chris Wynne, Heimo Stroissnig, Matthew Smith, Paul Duijzings, Ruth Ruffieux, Joanna Sobierska, Hendrik Otto, Abid Sattar, Halimu Haliduola
Journal: Journal of the American Academy of Dermatology (2023)
42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)
Authors: Dafna D. Gladman, Michael Starr, Roberto Ranza, Ana-Maria Bravo Perdomo, Marcie Strauss, May Shawi, Chenglong Han
Journal: Journal of the American Academy of Dermatology (2023)
42900 Understanding comorbidities and concomitant medication patterns in patients with moderate- to-severe plaque psoriasis in the real-world Psoriasis Study of Health Outcomes (PSoHO)
Authors: Luis Puig, Knut Schäkel, Adam Reich, Shirin Zaheri, Milan Tjioe, Alan Brnabic, Niek de Hoog, Catherine Reed, Christopher Schuster, Elisabeth Riedl
Journal: Journal of the American Academy of Dermatology (2023)
43916 Efficacy and Safety of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in the Presence or Absence of Comorbid Asthma or Allergic Rhinitis: A Post Hoc Pooled Analysis of JADE COMPARE and JADE DARE
Authors: Jacob P. Thyssen, Jonathan I. Silverberg, Gil Yosipovitch, Shawn G. Kwatra, Jose-Manuel Carrascosa, Patrick M. Brunner, Irina Lazariciu, Claire Feeney, Francisco J. Rebollo, Herwig Koppensteiner
Journal: Journal of the American Academy of Dermatology (2023)
In silico discovery of repetitive elements as key sequence determinants of 3D genome folding
Authors: Laura M. Gunsalus, Michael J. Keiser, Katherine S. Pollard
Journal: Cell Genomics (2023)

Natural and experimental genetic variants can modify DNA loops and insulating boundaries to tune transcription, but it is unknown how sequence perturbations affect chromatin organization genome wide. We developed a deep-learning strategy to quantify the effect of any insertion, deletion, or substitution on chromatin contacts and systematically scored millions of synthetic variants. While most genetic manipulations have little impact, regions with CTCF motifs and active transcription are highly sensitive, as expected. Our unbiased screen and subsequent targeted experiments also point to noncoding RNA genes and several families of repetitive elements as CTCF-motif-free DNA sequences with particularly large effects on nearby chromatin interactions, sometimes exceeding the effects of CTCF sites and explaining interactions that lack CTCF. We anticipate that our disruption tracks may be of broad interest and utility as a measure of 3D genome sensitivity, and our computational strategies may serve as a template for biological inquiry with deep learning.
42577 Application of the new clinical guidelines in frontal fibrosing alopecia of the male
Authors: Ana Melian-Olivera, Patricia Burgos-Blasco, Gerald Selda-Enriquez, Ángela Hermosa-Gelbard, Claudia Bernandez-Guerra, Daniel Ortega-Quijano, Sergio Vaño-Galvan, David Saceda-Corralo
Journal: Journal of the American Academy of Dermatology (2023)
41481 Expert Consensus on Priority Research Gaps in Nutrition and Lifestyle Factors in Hidradenitis Suppurativa: Delphi Consensus
Authors: Rishab Revankar, Mika Takaichi, Jordan Haag, Terri Shih, Margaret Gall, Jennifer Hsiao, Vivian Shi, Afsaneh Alavi
Journal: Journal of the American Academy of Dermatology (2023)
39861 Deucravacitinib, a Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Psoriasis: Absolute PASI Outcomes in a Phase 3 Trial
Authors: Yukari Okubo, Shinichi Imafuku, Yayoi Tada, Mamitaro Ohtsuki, Yanqiu Shao, Elizabeth Colston, Andrew Napoli, Lauren Hippeli, Subhashis Banerjee, Akimichi Morita
Journal: Journal of the American Academy of Dermatology (2023)
42242 Biodiversity of feet microbiome in patients with pitted keratolysis: correlation with pitted score and unpleasant odor severity
Authors: Sasitorn Yenyuwadee, Charussri Leeyaphan, Sumanas Bunyaratavej, Penvadee Pattanaprichakul, Patcha Poungsombat, Kanyalak Munprom, Sakda Khoomrung, Kanokvalai Kulthanan, Chatchawan Srisawat
Journal: Journal of the American Academy of Dermatology (2023)
42564 Comparison of long-term drug survival and safety of biologic agents in patients with moderate- to-severe psoriasis vulgaris
Authors: Heeyeon Kim, Hyungrye Noh, Dong Min Shin, Donghwi Jang, Se Jin Oh, Ji Hye Park, Jong Hee Lee, Dong-Youn Lee, Joon Ho Shim, Joo-Heung Lee
Journal: Journal of the American Academy of Dermatology (2023)
44183 Retrospective analysis reveals that sepsis in cutaneous T-cell lymphoma disproportionately affects Black patients
Authors: Teresa Griffin, Madeline Hooper, Francesca Veon, Gail Enriquez, Morgan Nguyen, Cameron Grimes, Tessa LeWitt, Slaton Case, Joan Guitart, Michael Burns, Xiaolong Zhou
Journal: Journal of the American Academy of Dermatology (2023)
43117 Integrated safety analysis of ritlecitinib in adolescent patients with alopecia areata from the randomized, placebo-controlled ALLEGRO phase 2b/3 and ongoing open-label phase 3 ALLEGRO-LT studies
Authors: Jennifer Soung, Brett King, Christos Tziotzios, Lidia Rudnicka, Pascal Joly, Melinda Gooderham, Rodney Sinclair, Fan Zhang, Helen Tran, Robert Wolk
Journal: Journal of the American Academy of Dermatology (2023)
43943 Evaluation Of Sebogenesis Inhibition By A Combination Of Glyceryl Laurate, Zinc Gluconate And Lens Esculenta Seed Extract On Sebocytes Culture In A Testosterone Induced Model
Authors: Ana Coutinho, Fernanda Beltrao, Raphael Pinheiro, Anne-Laure Gaudry
Journal: Journal of the American Academy of Dermatology (2023)
44105 Hydradermabrasion Treatment Outcomes in a Pediatric and Adult Patient with Seborrheic Dermatitis
Authors: Ora Raymond, Zehara Abidi, Sukhmani Pannu, Hanaa Ahmed, Nathalie Ly, Sophia Fruechte, Maria Hordinsky, Neil Sadick, Ronda S. Farah, Suleima Arruda
Journal: Journal of the American Academy of Dermatology (2023)
43744 Bimekizumab in bDMARD-naïve patients with psoriatic arthritis and skin involvement: Analysis of radiographic progression at Week 16 of BE OPTIMAL, a phase 3, multicenter, randomized, placebo- controlled, active reference study
Authors: Joseph F. Merola, Akihiko Asahina, Paolo Gisondi, Diamant Thaçi, Dafna D. Gladman, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Jason Coarse, Robert Landewé
Journal: Journal of the American Academy of Dermatology (2023)
42835 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a phase 3 trial: Assessment of Pruritus
Authors: Andrew Blauvelt, Zoe Draelos, Melinda Gooderham, Edward Lain, Angela Moore, Kim Papp, Matthew Zirwas, David Krupa, Patrick Burnett, David Berk, David Chu
Journal: Journal of the American Academy of Dermatology (2023)
43603 No association of isotretinoin exposure with risk of inflammatory bowel disease: a systematic review with meta-analysis and trial sequential analysis
Authors: Ching-Chi Chi, Chia-Ling Yu, Po-Yi Chou, Chih-Sung Liang, Li-Huei Chiang, Tzu- Yu Wang, Yu-Kang Tu
Journal: Journal of the American Academy of Dermatology (2023)
43938 Total Vitiligo Area Scoring Index Response Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies
Authors: David Rosmarin, John E. Harris, Albert Wolkerstorfer, Mark Lebwohl, Khaled Ezzedine, Thierry Passeron, Deanna Kornacki, Haobo Ren, Kathleen Butler, Julien Seneschal
Journal: Journal of the American Academy of Dermatology (2023)
41552 Non-visibility of Suspicious Lesions by Patients Leads to Later Detection of Melanoma
Authors: Emily Everdell, Hemali Shah, Rose Parisi, Paul Feustel, Lindy Davis
Journal: Journal of the American Academy of Dermatology (2023)

Background: Earlier detection of melanoma leads to better outcomes and a more favorable prognosis.[1] There is a relationship between anatomic location of melanoma and prognosis, but how visibility of the lesion relates to prognosis has not been studied.[2-5] We aimed to determine if visibility of suspicious lesions by patients leads to earlier diagnosis of melanoma. We conducted a retrospective analysis of 382 patients diagnosed with invasive melanoma at one institution between 8/1/2018 and 11/1/2021. Visible lesions were defined as occurring in locations visible to the patient, as defined by review of physical exam in chart and operating room positioning. Low-risk stage includes IA, IB, IIA, IIIA. High-risk stage includes IIB, IIC, IIIB, IIIC, IIID, IV. Data were analyzed by chi-square analysis. Two-hundred patients were diagnosed with T1 lesions, 87 T2 lesions, 55 T3 lesions, and 40 T4 lesions. The 181 patients with nonvisible lesions (47%) were significantly more likely to have T3 or T4 versus T1 or T2 tumors as compared to visible lesions (p<0.001). Sixty-three patients had positive nodes; of these, 60% were patients with nonvisible lesions (p=0.024). Fifty-eight (67%) patients diagnosed with high-risk stage were in nonvisible areas compared to visible areas (p<0.001). This study is the first to show that non-visibility of suspicious lesions by patients may lead to later detection of melanoma. This highlights that dermatologists and primary care physicians must pay particularly close attention to areas less visible to patients. These findings identify patient non-visibility as a high-risk factor for advanced melanoma.
42255 Prior Treatment Usage in Patients With Atopic Dermatitis Initiating Dupilumab: an Update From The GLOBOSTAD Registry
Authors: Silvia Ferrucci, Mariateresa Rossi, Daria Fomina, Hilde Lapeere, Wen-Hung Chung, Thrasyvoulos Tzellos, Anne-Claire Fougerousse, Jiangming Wu, Kwinten Bosman, Marius Ardeleanu
Journal: Journal of the American Academy of Dermatology (2023)
41176 Psoriasis And Mental Health Comorbidities: A Multinational Analysis Using the Global Healthcare Study on Psoriasis (GHSP)
Authors: Hannah Peterson, Edwin Korouri, Paige Kingston, Kathryn Lee, Margaret Huang, Danielle Yee, Rosario Aguero, Kevin Artiga, Fernando Valenzuela, Ricardo Romiti, Johannes Didaskalu, Alexander Egeberg, Hazel H. Oon, Julia-Tatjana Maul, April W. Armstrong
Journal: Journal of the American Academy of Dermatology (2023)
44063 Short Term Efficacy and Racial and Ethnic Diversity in Risankizumab Phase 3 Clinical Trials for Treatment of Moderate-to-Severe Plaque Psoriasis
Authors: Andrew Alexis, Melinda Gooderham, Shawn G. Kwatra, Ahmad Amin, Ramon Espaillat, Mark Kaldas, Ran Liu, Deanne M. Dilley, Ranjeeta Sinvhal, Chudi Nduaka, Benjamin Lockshin
Journal: Journal of the American Academy of Dermatology (2023)
40704 Dupilumab treats lenalidomide-associated rashes and plays a potentially tumor-suppressive role in multiple myeloma patients
Authors: Shayan Owji, Danielle Dubin, Jade Young, Dina Poplausky, Daniel Yassky, Joseph Han, Kathryn Tan, Sundar Jagannath, Samir Parekh, Nicholas Gulati
Journal: Journal of the American Academy of Dermatology (2023)
43759 Insights Into Baseline Demographics and Disease Characteristics in Subjects With Notalgia Paresthetica
Authors: Brian S. Kim, Robert Bissonnette, April Armstrong, David M. Pariser, Scott Guenthner, Kristine Nograles, Joana Goncalves, Josh Cirulli, Catherine Munera, Cathy Smolens, Mark Lebwohl
Journal: Journal of the American Academy of Dermatology (2023)
42766 JAK of All Trades: Novel Off-Label Use of the Systemic JAK Inhibitor Upadacitinib As An Adjunct to Systemic Biologic Therapy for Various Immune-Mediated Inflammatory Diseases of the Skin
Authors: Abrahim Abduelmula, Lauren Wong, Lauren A. Stark, Fernejoy Colango, Aizel Castejon, Rochelle Lake, Brian D. Rankin, Alexander Rimke, Vimal H. Prajapati
Journal: Journal of the American Academy of Dermatology (2023)
42587 M89PF contains Vichy volcanic mineralizing water and probiotic fractions and is beneficial in facial skin stressed by ablative procedures and facial skin manifestations: results from an observational study performed in Southeast Asia
Authors: Stephanie Leclerc-Mercier, Chidchon Sakjirapapong, Kuanjira Wongkietkachorn, Vuong The Bich Thanh, Catherine Delva, Lorela Gjyshi
Journal: Journal of the American Academy of Dermatology (2023)
41662 Brodalumab’s profile for the treatment of patients with moderate-to-severe plaque psoriasis in the Greek everyday clinical practice: Results of the BrIDGE study
Authors: Pantelis Panagakis, Dimitrios Ioannides, Dimitrios Rigopoulos, Evangelia Papadavid, Elisavet Lazaridou, Efterpi Zafeiriou, Sophia Georgiou, Florentina Delli, Markos Papakonstantis, Eleftheria Tampouratzi, Konstantinos Sfaelos
Journal: Journal of the American Academy of Dermatology (2023)
41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata
Authors: Jerry Shapiro, Justin Ko, Alexander Egeberg, Najwa Somani, Jakub Jedynak, Hitoe Torisu-Itakura, Guanglei Yu, Na Lu, Brittany Craiglow
Journal: Journal of the American Academy of Dermatology (2023)
43731 Dupilumab Reduces Itch in Children with Moderate-to-Severe Atopic Dermatitis Aged 6 Months to 5 Years
Authors: Amy S. Paller, Elaine C. Siegfried, Gil Yosipovitch, Shawn G. Kwatra, Amy Praestgaard, Zhixiao Wang, Randy Prescilla
Journal: Journal of the American Academy of Dermatology (2023)
42148 Stringent Disease Activity Control at 2 Years Across Psoriatic Arthritis Domains Irrespective of Baseline Characteristics in Patients Treated with Guselkumab: Post-Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Authors: Christopher T. Ritchlin, Philip J. Mease, Wolf-Henning Boehncke, John Tesser, Soumya D. Chakravarty, Emmanouil Rampakakis, May Shawi, Joseph F. Merola, Iain B. McInnes, Atul Deodhar
Journal: Journal of the American Academy of Dermatology (2023)
41551 Feasibility of using an integrated RCM-OCT device to identify thin Basal Cell Carcinomas amenable to ablative therapy with a Er:YAG laser: A Prospective Observational Study
Authors: Larissa Pastore, Zaeem Nazir, Rachel Manci, Aditi Sahu, Miguel Cordova, Nicusor Iftimia, Ashfaq Marghoob, Milind Rajadhyaksha, Chih-Shan Jason Chen
Journal: Journal of the American Academy of Dermatology (2023)
43129 A series of 69 COVID-related dermatosis with biopsy, immunohistochemistry with antiSpike 3 and in situ hybridization and PCR: a critical reappraisal of COVID-19 skin involvement.
Authors: Mar Llamas-Velasco, Javier Fraga, Ana Rodríguez-Villa Lario, Alba Catalá, Yosmar Carolina Pérez-González, Beatriz Butrón- Briz, Cristina Galván, Ricardo Ruiz-Villaverde, Javier Sánchez-Pérez, Thomas Wiesner, Dieter Metze
Journal: Journal of the American Academy of Dermatology (2023)
42889 Long-term efficacy and safety of dutasteride in Korean men with androgenetic alopecia: 5-year follow-up data exhibiting clinical improvement with sustained efficacy
Authors: Ji-Hoon Lim, Sang-Min Choi, Soon-Hyo Kwon, Woo-Young Sim, Bark-Lynn Lew
Journal: Journal of the American Academy of Dermatology (2023)
40665 Efficacy of Apremilast in Patients With Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results From the Phase 3 DISCREET Trial
Authors: Joseph F. Merola, Lawrence Charles Parish, Lyn Guenther, Charles Lynde, Jean-Philippe Lacour, Petra Staubach, Sue Cheng, Cynthia Deignan, Mindy Chen, Kim Papp
Journal: Journal of the American Academy of Dermatology (2023)
43944 Improvements in Manifestations of Active Psoriatic Arthritis With Risankizumab Treatment After Intolerance or Inadequate Response to Prior Biologic Therapy: Subgroup Analyses From the KEEPsAKE 2 Trial
Authors: Bruce Strober, Alan Kivitz, Andrew Östör, Byron Padilla, Cuiyong Yue, Huzefa Photowala, Joseph F. Merola
Journal: Journal of the American Academy of Dermatology (2023)
40510 The Prevalence of Sunscreen Use in Jazz Festival Attendees
Authors: Grace McCollam, Kendall McDaniel, Arman Torosian, Julien Bourgeois, Rebecca Yim, Kezia Surjanto, Samantha Albucker, Soo Hyun Choi, Jasira Ziglar, Leah Jacob, Andrea Murina
Journal: Journal of the American Academy of Dermatology (2023)
40900 Tralokinumab modulates the transcriptomic profile of lesional and non-lesional skin in adolescents with moderate-to-severe atopic dermatitis assessed by tape-stripping
Authors: Ana Pavel, Eric Simpson, Weily Soong, Richard J. Antaya, Shinichi Imafuku, Steven Pilger, Thomas Litman, Mads A. Røpke, Petra Arlert, Emma Guttman- Yassky
Journal: Journal of the American Academy of Dermatology (2023)